Identifai-genetics

Identifai-genetics is a cutting-edge digital bioinformatics company developing a liquid biopsy test using maternal blood samples for the non-invasive detection of fetal genetic diseases early in pregnancy. The solution is based on standard sequencing results (obtained from any sequencing service provider) and utilizes proprietary algorithms + advanced software to separate the fetal and maternal genomes, enabling early genetic disease detection at an order of magnitude beyond the capabilities of existing NIPT (Non-Invasive Prenatal Testing), with an accuracy rate of approximately 99%.